Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high64.800 02/01/18
52 week low9.525 19/07/17
52 week change 11.500 (37.10%)
4 week volume2,401,037 30/03/18
price42.500
price date1524663947
close44.500

Media for (AVO)

Latest NewsMore

Holding(s) in Company

RNS Number: 8631J Advanced Oncotherapy PLC 05 April 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Advanced O...

Advanced Oncotherapy says Yantai Cipu, Chinese pharma distribution company talks continue

Advanced Oncotherapy said Tuesday that discussions between Yantai Cipu, through its affiliated entity Liquid Harmony, ...

Update on Distribution Agreement

RNS Number: 5966J Advanced Oncotherapy PLC 03 April 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Update on Distribution Agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that discussions between Yantai Cipu, through its affil...

Hardman & Co Research: Confidence greatly boosted

RNS Number: 3227H Advanced Oncotherapy PLC 12 March 2018 Hardman & Co Research: Confidence greatly boosted Confidence greatly boosted: Advanced Oncotherapy (AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology developed originally at the world-renowned CERN. Major technical milestones w...

Holding(s) in Company

RNS Number: 8369F Advanced Oncotherapy PLC 23 February 2018 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting...

Completion of the Subscription Agreement

RNS Number: 0737F Advanced Oncotherapy PLC 16 February 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Completion of the Subscription Agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that in relation to the announcement date...

Result of Meeting

RNS Number: 6752C Advanced Oncotherapy PLC 23 January 2018 23 January 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Result of GM Advanced Oncotherapy plc (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the General Meeting held earlier today, all re...

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 40,000 shares in the company on the 11th January 2018 at a price of 54.5...

Fundamental DataMore

EPS-17.01
Dividend yield0 %

Latest discussion posts More

  • Re: Up 15% and no news

    Still more upward pressure, news must be imminent! Volumes are tiny though. If bad news was coming then we'd see bigger volumes and more of a drift.
    19-Apr-2018
    fish lips
  • Re: Up 15% and no news

    Very low turnover
    18-Apr-2018
    Dubliner2
  • Up 15% and no news

    Anybody heard anything. Maybe the China deal has been signed?
    18-Apr-2018
    Deckhard

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO